Cancer colique en occlusion : quelle prise en charge en 2022 ? [Obstructed colon cancer: which strategy in 2022?]

Détails

Ressource 1Demande d'une copie Sous embargo jusqu'au 15/12/2023.
Accès restreint UNIL
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_4C3D99FB8614
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Cancer colique en occlusion : quelle prise en charge en 2022 ? [Obstructed colon cancer: which strategy in 2022?]
Périodique
Revue medicale suisse
Auteur⸱e⸱s
Girardot-Miglierina A., Kefleyesus A., Clerc D., Grass F., Demartines N., Hübner M., Hahnloser D.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
15/06/2022
Peer-reviewed
Oui
Volume
18
Numéro
786
Pages
1192-1199
Langue
français
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
The key priority for obstructed colon cancer (OCC) is urgent resolution of the large bowel obstruction with ideally no compromise of oncological outcomes and low initial and permanent ostomy rates. Proactive management is pivotal to decrease the risk of perforation and septic shock. Staged procedures have an important place to provide optimal treatment and offer similar treatment and outcomes as in the elective setting. The approach is tailored to the patient's condition, the oncological situation and expertise of the available surgical team. This overview concludes by proposing a comprehensive treatment algorithm for individualized treatment of OCC.
Mots-clé
Colon, Colonic Neoplasms/complications, Colonic Neoplasms/therapy, Elective Surgical Procedures, Humans, Intestinal Obstruction/surgery
Pubmed
Open Access
Oui
Création de la notice
05/07/2022 12:40
Dernière modification de la notice
01/09/2022 6:40
Données d'usage